References

  1. Giraudet G, Wibaut B, Ducloy A-S et al. Thrombocytémie essentielle et grossesse. Gynecol Obstet Fertil. 2011; 39(4) :205-210. PubMed | Google Scholar

  2. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007; 110(1): 1092-1097. PubMed | Google Scholar

  3. Beer PA, Green AR. Pathogenesis and management of essential thrombocythemia. Hematology Am Soc Hematol Educ Program. 2009; 2009(1):621-628. PubMed | Google Scholar

  4. Rossi C, Randi ML, Zerbinati P et al. Coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med. 1998; 244(1):49-53. PubMed | Google Scholar

  5. Rüfera A, Toblerb A, Tichellic A et al. Syndromes myéloprolifératifs: polycythémie vraie, thrombocytémie essentielle, ostéomyélofibrose. Forum Med Suisse. 2003; 3(43) : 1026-1033. PubMed | Google Scholar

  6. Cortelazzo S, Finazzi G, Ruggeri M, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med. 1995; 332 (17):1132-113. PubMed | Google Scholar

  7. Wehmeir A, Daum I, Jamin H et al. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorder: Retrospective analysis of 260 patients. Ann hematol. 1991; 63(2): 101-106. PubMed | Google Scholar

  8. Randi ML, Fabris F, Cella G et al. Cerebral vasculaire accidents in young patients with essential thrombocythemia: relation with other known cardiovascular risk factors. Angiology. 1998; 49(6):477-504. PubMed | Google Scholar

  9. Koh KK, Cho SK, Kin SS, et al. Coronary vasospasm, multiple coronary thrombosis, unstable angina and essential thrombocytosis. Int J Cardiol. 1993; 41(2):168-170. PubMed | Google Scholar

  10. Michaels AD, Whisenant B, MacGregor JS. Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia. Clin Cardiol. 1998; 21(2):134-138. PubMed | Google Scholar